LXEO US Equity

Lexeo Therapeutics, Inc.

Health Care · Biological Products, (No Diagnostic Substances) · CIK 1907108 · FY ends Dec 31

$5.37

+0.44 (+8.92%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Documents

3 of 3 10-Ks readable here

Period end	Filed	Form	Read here	EDGAR
2025-12-31	2026-03-30	10-K	read · risk factors · MD&A	index · original · 0001193125-26-132085
2024-12-31	2025-03-24	10-K	read · risk factors · MD&A	index · original · 0000950170-25-043486
2023-12-31	2024-03-11	10-K	read · risk factors · MD&A	index · original · 0000950170-24-028941

61 captions · 3 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

61 captions across 3 filings4 added0 dropped57 in every year3 of 3 10-Ks on file are cached here

Risk-factor caption

2023

2024

2025

Years

●

3 rw

●

3 rw

●

3 rw

●

3 rw

The filer's own 10-K text · 3 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

3 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

Filed	Period end	Document words	Item 1A words	Negation / 10k	Hedging / 10k	Filing
2024-03-11	2023-12-31	105,609	48,333	67.7	204.81	read · EDGAR ↗
2025-03-24	2024-12-31	100,073	49,210	72.85	199.05	read · EDGAR ↗
2026-03-30	2025-12-31	99,934	49,939	72.05	203.63	read · EDGAR ↗

The filer's own 10-K text · 3 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.